JP Morgan provided color on St. Jude Medical STJ ahead of the company's quarterly earnings report, which is due on July 20.
In a research report published today, JP Morgan states, “St. Jude is scheduled to report 2Q results next Wednesday, July 20th. Our forecast
calls for revenues of $1.430B (+8.9% reported, +4.9% constant currency) and EPS of
$0.84 (+6.0%).”
At the moment, JP Morgan has an Overweight rating and a price target of $57 placed on the company's stock. On Thursday, STJ closed the day at $45.55.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in